pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News · Immunology
996
stories
Aug 28, 26
FDA green lights Priovant drug for rare skin disease
biopharma dive
Aug 28, 26
STAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more
stat
Aug 28, 26
Priovant nabs first FDA approval for targeted tablet in dermatomyositis
biospace
Aug 28, 26
AstraZeneca, Amgen poised to challenge Dupixent’s reign with esophagitis win
biospace
Aug 28, 26
AusperBio adds $120M series C to advance hep B oligo therapy through phase 3 and beyond
fiercebiotech
Aug 28, 26
STAT+: Cytokinetics details trial win for what could be its next approval
stat
Aug 28, 26
STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
stat
Aug 28, 26
Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio
fiercebiotech
Aug 28, 26
Vaccines take center stage at federal autism advisory committee
stat
Aug 28, 26
CAR T for autoimmune disease benefits from oncology’s lessons—and will deliver its own
biospace
Aug 28, 26
Genentech doubles down on ADC-resistant cancers with $1B DualityBio pact
fiercebiotech
Aug 27, 26
STAT+: FDA approves Roivant therapy for rare autoimmune disease
stat
Aug 27, 26
FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
fda press
Aug 27, 26
Michael Polansky has a new, skin-focused biotech. Don’t call it a drug company.
biopharma dive
Aug 27, 26
New data could widen use of AstraZeneca, Amgen immune disease drug
biopharma dive
Aug 27, 26
Generate Bio drops as data accidentally leaked ahead of European conference
biospace
Aug 27, 26
Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push
fiercebiotech
Aug 27, 26
AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitis
biospace
Aug 27, 26
CEPI backs push to bring Egyptian biotech's Ebola vaccine into clinic to curb fast-growing outbreak
fiercebiotech
Aug 27, 26
Osivax bags flu vaccine rights to pursue combination shot vision
fiercebiotech
Aug 27, 26
Opinion: I studied Reddit forums on menopause — and found what doctors are missing
stat
Aug 27, 26
STAT+: The mystery of Moderna’s magic algorithm
stat
Aug 27, 26
CAR Ts will only treat autoimmune diseases if we can scale delivery
biospace
Aug 26, 26
China in Global Clinical Development: Why Early Inclusion Matters
fiercebiotech
Aug 26, 26
Spyre tumbles as immune drug misses mark in rheumatoid arthritis
biopharma dive
Aug 26, 26
Zepbound may cut healthcare costs, study says; Summit, Akeso drug hits in another China trial
biopharma dive
Aug 26, 26
JATT mastermind launches latest biotech-focused SPAC via $60M IPO
fiercebiotech
Aug 26, 26
Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ shows
stat
Aug 26, 26
STAT+: When it comes to women’s health, money talks
stat
Aug 26, 26
FDA greenlights Abbott’s wearable sensor for capturing diabetic ketoacidosis
fiercebiotech
← prev
page 19 of 34
next →